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Background
We recently discovered two novel transcripts (CT-RCC-8
and CT-RCC-9) from HERV-E provirus located on chro-
mosome 6q expressed at variable levels in >50% of renal
cell carcinoma (RCC) samples but not in normal tissues
or other tumors. We also identified a peptide antigen
encoded by both of these HERV-E transcripts that was rec-
ognized by RCC-reactive T-cells isolated from a patient
with metastatic RCC who had dramatic regression of
tumor following a non-myeloablative allogeneic stem cell
transplant [1].
Results
Here, we show that HERV-E expression occurs only in
clear cell variants of RCC (ccRCC) that demonstrate loss
of normal Von Hippel-Lindau (VHL) protein. VHL trans-
genes introduced into VHL deficient ccRCC cell lines sup-
pressed HERV-E expression implying that VHL controls
provirus activity. Loss of functional pVHL has previously
been shown to increase expression of the hypoxia-induci-
ble factors HIF-1α and HIF-2α. We found a strong corre-
lation between the transcriptional activity of HIF-2α and
HERV-E provirus activation. We also found that expres-
sion of the HERV-E in ccRCC cell lines correlated with the
demethylation of the 5'LTR while normal tissues and
ccRCC cell lines without HERV-E expression showed
strong CpG methylation in this region. Once activated,
HIF-2α binds DNA at the consensus HRE (core HRE
sequence is CGTG) in the target gene promoters, and a
HRE motif was identified in 5'LTR of the HERV-E. It is
therefore possible that methylation of 5'LTR CpGs includ-
ing the HRE CpG can explain silencing of HERV-E even in
the presence of active transcriptional factors. The mecha-
nism protecting the HERV-E promoter from methylation
in VHL defective ccRCC lines leading to expression of pro-
viral genes remains under investigation.
Conclusion
These findings provide insight into mechanisms regulat-
ing HERV activation in human malignancies. The contri-
bution of HERV-E to kidney tumorigenesis warrants
further elucidation.
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